Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Stereotactic-guided Biopsy Instrument Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Stereotactic-guided Biopsy Instrument Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Type
    • 1.4.2 Needle-based Biopsy Instruments
    • 1.4.3 Localization Wires
    • 1.4.4 Procedure Trays
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Stereotactic-guided Biopsy Instrument Market Size Growth Rate by Application
    • 1.5.2 Breast Biopsy
    • 1.5.3 Lung Biopsy
    • 1.5.4 Colorectal Biopsy
    • 1.5.5 Prostate Biopsy
    • 1.5.6 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Stereotactic-guided Biopsy Instrument Market Size, Estimates and Forecasts
    • 2.1.1 Global Stereotactic-guided Biopsy Instrument Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Stereotactic-guided Biopsy Instrument Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Stereotactic-guided Biopsy Instrument Production Estimates and Forecasts 2015-2026
  • 2.2 Global Stereotactic-guided Biopsy Instrument, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Stereotactic-guided Biopsy Instrument Manufacturers Geographical Distribution
  • 2.4 Key Trends for Stereotactic-guided Biopsy Instrument Markets & Products
  • 2.5 Primary Interviews with Key Stereotactic-guided Biopsy Instrument Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Production Capacity
    • 3.1.1 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Stereotactic-guided Biopsy Instrument Manufacturers Market Share by Production
  • 3.2 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Revenue
    • 3.2.1 Global Top Stereotactic-guided Biopsy Instrument Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Stereotactic-guided Biopsy Instrument Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Stereotactic-guided Biopsy Instrument Revenue in 2019
  • 3.3 Global Stereotactic-guided Biopsy Instrument Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Stereotactic-guided Biopsy Instrument Production by Regions

  • 4.1 Global Stereotactic-guided Biopsy Instrument Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Stereotactic-guided Biopsy Instrument Regions by Production (2015-2020)
    • 4.1.2 Global Top Stereotactic-guided Biopsy Instrument Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Stereotactic-guided Biopsy Instrument Production (2015-2020)
    • 4.2.2 North America Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Stereotactic-guided Biopsy Instrument Production (2015-2020)
    • 4.3.2 Europe Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Stereotactic-guided Biopsy Instrument Production (2015-2020)
    • 4.4.2 China Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Stereotactic-guided Biopsy Instrument Production (2015-2020)
    • 4.5.2 Japan Stereotactic-guided Biopsy Instrument Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Stereotactic-guided Biopsy Instrument Import & Export (2015-2020)

5 Stereotactic-guided Biopsy Instrument Consumption by Region

  • 5.1 Global Top Stereotactic-guided Biopsy Instrument Regions by Consumption
    • 5.1.1 Global Top Stereotactic-guided Biopsy Instrument Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Stereotactic-guided Biopsy Instrument Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Stereotactic-guided Biopsy Instrument Consumption by Application
    • 5.2.2 North America Stereotactic-guided Biopsy Instrument Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Stereotactic-guided Biopsy Instrument Consumption by Application
    • 5.3.2 Europe Stereotactic-guided Biopsy Instrument Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Application
    • 5.4.2 Asia Pacific Stereotactic-guided Biopsy Instrument Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Stereotactic-guided Biopsy Instrument Consumption by Application
    • 5.5.2 Central & South America Stereotactic-guided Biopsy Instrument Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption by Application
    • 5.6.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Stereotactic-guided Biopsy Instrument Market Size by Type (2015-2020)
    • 6.1.1 Global Stereotactic-guided Biopsy Instrument Production by Type (2015-2020)
    • 6.1.2 Global Stereotactic-guided Biopsy Instrument Revenue by Type (2015-2020)
    • 6.1.3 Stereotactic-guided Biopsy Instrument Price by Type (2015-2020)
  • 6.2 Global Stereotactic-guided Biopsy Instrument Market Forecast by Type (2021-2026)
    • 6.2.1 Global Stereotactic-guided Biopsy Instrument Production Forecast by Type (2021-2026)
    • 6.2.2 Global Stereotactic-guided Biopsy Instrument Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Stereotactic-guided Biopsy Instrument Price Forecast by Type (2021-2026)
  • 6.3 Global Stereotactic-guided Biopsy Instrument Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Stereotactic-guided Biopsy Instrument Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Stereotactic-guided Biopsy Instrument Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 C. R. Bard, Inc. (U.S.)
    • 8.1.1 C. R. Bard, Inc. (U.S.) Corporation Information
    • 8.1.2 C. R. Bard, Inc. (U.S.) Overview
    • 8.1.3 C. R. Bard, Inc. (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 C. R. Bard, Inc. (U.S.) Product Description
    • 8.1.5 C. R. Bard, Inc. (U.S.) Related Developments
  • 8.2 Becton, Dickinson and Company (U.S.)
    • 8.2.1 Becton, Dickinson and Company (U.S.) Corporation Information
    • 8.2.2 Becton, Dickinson and Company (U.S.) Overview
    • 8.2.3 Becton, Dickinson and Company (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Becton, Dickinson and Company (U.S.) Product Description
    • 8.2.5 Becton, Dickinson and Company (U.S.) Related Developments
  • 8.3 Cook Group Incorporated (U.S.)
    • 8.3.1 Cook Group Incorporated (U.S.) Corporation Information
    • 8.3.2 Cook Group Incorporated (U.S.) Overview
    • 8.3.3 Cook Group Incorporated (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Cook Group Incorporated (U.S.) Product Description
    • 8.3.5 Cook Group Incorporated (U.S.) Related Developments
  • 8.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
    • 8.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information
    • 8.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Overview
    • 8.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Product Description
    • 8.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Related Developments
  • 8.5 Argon Medical Devices (U.S.)
    • 8.5.1 Argon Medical Devices (U.S.) Corporation Information
    • 8.5.2 Argon Medical Devices (U.S.) Overview
    • 8.5.3 Argon Medical Devices (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Argon Medical Devices (U.S.) Product Description
    • 8.5.5 Argon Medical Devices (U.S.) Related Developments
  • 8.6 B. Braun Melsungen AG (Germany)
    • 8.6.1 B. Braun Melsungen AG (Germany) Corporation Information
    • 8.6.2 B. Braun Melsungen AG (Germany) Overview
    • 8.6.3 B. Braun Melsungen AG (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 B. Braun Melsungen AG (Germany) Product Description
    • 8.6.5 B. Braun Melsungen AG (Germany) Related Developments
  • 8.7 Cardinal Health, Inc. (U.S.)
    • 8.7.1 Cardinal Health, Inc. (U.S.) Corporation Information
    • 8.7.2 Cardinal Health, Inc. (U.S.) Overview
    • 8.7.3 Cardinal Health, Inc. (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Cardinal Health, Inc. (U.S.) Product Description
    • 8.7.5 Cardinal Health, Inc. (U.S.) Related Developments
  • 8.8 Olympus Corporation (Japan)
    • 8.8.1 Olympus Corporation (Japan) Corporation Information
    • 8.8.2 Olympus Corporation (Japan) Overview
    • 8.8.3 Olympus Corporation (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Olympus Corporation (Japan) Product Description
    • 8.8.5 Olympus Corporation (Japan) Related Developments
  • 8.9 Boston Scientific Corporation (U.S.)
    • 8.9.1 Boston Scientific Corporation (U.S.) Corporation Information
    • 8.9.2 Boston Scientific Corporation (U.S.) Overview
    • 8.9.3 Boston Scientific Corporation (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Boston Scientific Corporation (U.S.) Product Description
    • 8.9.5 Boston Scientific Corporation (U.S.) Related Developments
  • 8.10 FUJIFILM Holdings Corporation (Japan)
    • 8.10.1 FUJIFILM Holdings Corporation (Japan) Corporation Information
    • 8.10.2 FUJIFILM Holdings Corporation (Japan) Overview
    • 8.10.3 FUJIFILM Holdings Corporation (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 FUJIFILM Holdings Corporation (Japan) Product Description
    • 8.10.5 FUJIFILM Holdings Corporation (Japan) Related Developments
  • 8.11 INRAD, Inc. (U.S.)
    • 8.11.1 INRAD, Inc. (U.S.) Corporation Information
    • 8.11.2 INRAD, Inc. (U.S.) Overview
    • 8.11.3 INRAD, Inc. (U.S.) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 INRAD, Inc. (U.S.) Product Description
    • 8.11.5 INRAD, Inc. (U.S.) Related Developments
  • 8.12 Medtronic plc (Ireland)
    • 8.12.1 Medtronic plc (Ireland) Corporation Information
    • 8.12.2 Medtronic plc (Ireland) Overview
    • 8.12.3 Medtronic plc (Ireland) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Medtronic plc (Ireland) Product Description
    • 8.12.5 Medtronic plc (Ireland) Related Developments

9 Stereotactic-guided Biopsy Instrument Production Forecast by Regions

  • 9.1 Global Top Stereotactic-guided Biopsy Instrument Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Stereotactic-guided Biopsy Instrument Regions Forecast by Production (2021-2026)
  • 9.3 Key Stereotactic-guided Biopsy Instrument Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Stereotactic-guided Biopsy Instrument Consumption Forecast by Region

  • 10.1 Global Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
  • 10.2 North America Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Stereotactic-guided Biopsy Instrument Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Stereotactic-guided Biopsy Instrument Sales Channels
    • 11.2.2 Stereotactic-guided Biopsy Instrument Distributors
  • 11.3 Stereotactic-guided Biopsy Instrument Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Stereotactic-guided Biopsy Instrument Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Stereotactic-guided Biopsy Instrument Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Stereotactic-guided Biopsy Instrument Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Stereotactic-guided Biopsy Instrument market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stereotactic-guided Biopsy Instrument market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Stereotactic-guided Biopsy Instrument market is segmented into
    Needle-based Biopsy Instruments
    Localization Wires
    Procedure Trays
    Others

    Segment by Application, the Stereotactic-guided Biopsy Instrument market is segmented into
    Breast Biopsy
    Lung Biopsy
    Colorectal Biopsy
    Prostate Biopsy
    Others

    Regional and Country-level Analysis
    The Stereotactic-guided Biopsy Instrument market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Stereotactic-guided Biopsy Instrument market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Stereotactic-guided Biopsy Instrument Market Share Analysis

    Stereotactic-guided Biopsy Instrument market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Stereotactic-guided Biopsy Instrument by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Stereotactic-guided Biopsy Instrument business, the date to enter into the Stereotactic-guided Biopsy Instrument market, Stereotactic-guided Biopsy Instrument product introduction, recent developments, etc.
    The major vendors covered:
    C. R. Bard, Inc. (U.S.)
    Becton, Dickinson and Company (U.S.)
    Cook Group Incorporated (U.S.)
    Devicor Medical Products, Inc., (Leica Biosystems) (Germany)
    Argon Medical Devices (U.S.)
    B. Braun Melsungen AG (Germany)
    Cardinal Health, Inc. (U.S.)
    Olympus Corporation (Japan)
    Boston Scientific Corporation (U.S.)
    FUJIFILM Holdings Corporation (Japan)
    INRAD, Inc. (U.S.)
    Medtronic plc (Ireland)

    Buy now